HFA Premium Access

Readmissions in heart failure patients: a portuguese administrative database study from 2008 to 2017

Congress Presentation

About the speaker

Mrs Marisa Pardal

Portuguese Institute of Hygiene and Tropical Medicine, Lisboa (Portugal)
0 follower

8 more presentations in this session

Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results

Speaker: Doctor L. Niskanen (Helsinki, FI)


Testing for iron deficiency and use of ferric carboxymaltose in patients with heart failure: need for implementation? data from the swedish heart failure registry

Speaker: Doctor P. Becher (Hamburg, DE)


Disparities in follow-up rates after heart failure hospitalisation decreased during the COVID-19 pandemic

Speaker: Doctor Z. Hughes (Chicago, US)


Different renal function patterns in patients with acute heart failure: relationship with outcome and congestion

Speaker: Associate Professor A. Palazzuoli (Siena, IT)


No change in predicted risk for in-hospital and one-year mortality in patients hospitalised with heart failure during as compared to before the COVID-19 pandemic

Speaker: Doctor J. Simkowski (Chicago, US)


Access the full session

Acute Heart Failure - Epidemiology, Prognosis, Outcome

Speakers: Mrs M. Pardal, Doctor L. Niskanen, Doctor P. Becher, Doctor Z. Hughes, Associate Professor A. Palazzuoli...

About the event


Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb